FOURTH AMENDMENT TO DRUG DISCOVERY COLLABORATION AGREEMENTDiscovery Collaboration Agreement • November 4th, 2008 • Array Biopharma Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 4 (“Fourth Amendment”), effective as of July 25, 2008 (“Amendment Date”), is entered into by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), (collectively, the “Parties” or individually, a “Party”).
FIFTH AMENDMENT TO DRUG DISCOVERY COLLABORATION AGREEMENTDiscovery Collaboration Agreement • November 4th, 2008 • Array Biopharma Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 5 (“Fifth Amendment”), effective as of September 1, 2008 (“Amendment Date”), is entered into by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), (collectively, the “Parties” or individually, a “Party”).
